RxDoctor Payments Data

Jill Willard, APRN

Adult Health · Temple Terrace, FLNPI 1316381593

Payments from drug & device makers

$2,827in general payments, 2019–2025

Across 145 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$327
  • Lilly USA, LLC$256
  • E.r. Squibb & Sons, L.L.C.$196
  • Sanofi$186
  • Eisai Inc.$154
  • AstraZeneca$153
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$2,827100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,827 in reported general payments places this provider in the 80th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$5,205
Medicare patients
57
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate13$74
Metronidazole15$20

Paid to pharmacies, not to this prescriber.

Other adult health in Temple Terrace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →